skip to main content


Apr 9, 2018

Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al.

Featuring: Peter Wilcox and Marian Wolanski

We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s blockbuster drug HUMIRA.  This case was settled during the discovery phase as part of a global settlement between AbbVie and Samsung Bioepis. 


  • Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy